drugset / Trial / NCT04078425

Non Invasive Assessment of Heart Failure

NCT04078425 ↗

Phase 0 Unknown 100 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

1. To Identify the role of aldosterone antagonist in patients of heart failure with preserved ejection fraction. 2. Portray the health profile of heart failure patients admitted in internal medicine department either heart failure with reduced ejection fraction or heart failure with preserved ejection fraction. 3. To compare between patients of right and left sided heart failure by biomarkers and parameters of echocardiographgy 4. Vitamin D and its relation to cardiovascular disease and heart failure.

Timeline

Start
2020-03-01
Primary completion
2022-03-01
Completion
2022-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplernone Unknown — —

Indications